EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Further Considerations on How to Improve Phage Therapy Experimentation, Practice, and Reporting: Pharmacodynamics Perspectives

Stephen T Abedon iD

PHAGE: Therapy, Applications, and Research · 01.06.2022 · 3 (2) · 98-111

DOI: 10.1089/phage.2022.0019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PHAGE: Therapy, Applications, and Research, online erschienen am 16.06.2022. Verfasst von Stephen T Abedon. Beteiligte Einrichtung: Department of Microbiology, The Ohio State University, Mansfield, Ohio, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phage therapy uses bacterial viruses (bacteriophages) to infect and kill targeted pathogens. Approximately one decade ago, I started publishing on how possibly to improve upon phage therapy experimentation, practice, and reporting. Here, I gather and expand upon some of those suggestions. The issues emphasized are (1) that using ratios of antibacterial agents to bacteria is not how dosing is accomplished in the real world, (2) that it can be helpful to not ignore Poisson distributions as a means of either anticipating or characterizing phage therapy success, and (3) how to calculate a concept of ‘inundative phage densities.’ Together, these are issues of phage therapy pharmacodynamics, meaning they are ways of thinking about the potential for phage therapy treatments to be efficacious mostly independent of the details of delivery of phages to targeted bacteria. Much emphasis is placed on working with Poisson distributions to better align phage therapy with other antimicrobial treatments.

Schlagwörter

Stichwörter der Autor:innen

MOIbacteriophage therapyhalf-lifeinundative phage densitymultiplicity of infectionpharmacology

Autor:innen und Institutionen

  • Department of Microbiology, The Ohio State University, Mansfield, Ohio, USA.

ORCID-Profile: Stephen T Abedon

Förderung

  • NIAID NIH HHS

Zitieren

APA

Abedon, S. T. (2022). Further Considerations on How to Improve Phage Therapy Experimentation, Practice, and Reporting: Pharmacodynamics Perspectives. PHAGE: Therapy, Applications, and Research, 3(2), 98-111. https://doi.org/10.1089/phage.2022.0019

Vancouver

Abedon ST. Further Considerations on How to Improve Phage Therapy Experimentation, Practice, and Reporting: Pharmacodynamics Perspectives. PHAGE: Therapy, Applications, and Research. 2022;3(2):98-111. doi:10.1089/phage.2022.0019

BibTeX
@article{Abedon2022,
  author = {Abedon, Stephen T},
  title = {Further Considerations on How to Improve Phage Therapy Experimentation, Practice, and Reporting: Pharmacodynamics Perspectives},
  journal = {PHAGE: Therapy, Applications, and Research},
  year = {2022},
  volume = {3},
  number = {2},
  pages = {98--111},
  doi = {10.1089/phage.2022.0019}
}
Kostenlos starten →